semaglutide weight loss trial 🚨 Oral 25 mg delivers double-digit in OASIS-4 (Phase 3 trial) - Semaglutide 7.2mg achieved 20.7% weight

An OZEMPIC pen must never be shared between patients, even if the needle is changed [see Warnings and Precautions (5.4 )]

Ethanol also reduces Tuj-1 expression, an early stage of neural differentiation marker, and protein kinase A (PKA) and cAMP-response element binding protein (CREB) phosphorylation

Semaglutide therapy allows for significant weight reduction without invasive surgery, making it an ideal choice for those who have struggled with conventional diets or exercise plans

In February 2026, the European Commission approved the use of a higher 7.2 mg maintenance dose of Wegovy for adults across 27 countries in the European Union